ITMCTR2000002972招募中1 期
A prospective, randomized,open, multi-center clinical trial evaluating the efficiency and safety of Reduning injection in the treatment of novel coronavirus pneumonia (COVID-19)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •(1) Comply with the diagnostic criteria of Pneumonitis Diagnosis and Treatment Scheme for New Coronavirus Infection (Trial Version 5);
- •(2) The classification was judged as common and severe type;
- •(3) Having one or more symptoms of fever, cough and fatigue when entering the group;
- •(4) The diagnosis time does not exceed 48 hours;
- •(5) Aged >= 18 years.
排除标准
- •(1) Immunodeficiency diseases, or those using immunosuppressive agents or glucocorticoids within the past 3 months;
- •(2) Pregnancies, pregnant women and lactating women;
- •(3) An allergic condition, such as a history of allergies to two or more drugs or foods, or a known allergy to the ingredients in this test);
- •(4) Psychotic patients, or those without self-knowledge ability;
- •(5) Patients whose estimated survival time does not exceed 48 hours from the start of screening;
- •(6) Tracheal intubation and mechanical ventilation have been performed during screening;
- •(7) Other problems that doctor's judgment is not suitable for the study.
研究者
相似试验
招募中
4 期
A randomized, controlled, open, multi-center clinical study on the effectiveness and safety of Kangai injection in the treatment of cancer-induced fatigueTumor patients (lung cancer, rectal cancer, malignant lymphoma, gynecological malignancy)ITMCTR2100004974Jiangsu Provincial Hospital of Traditional Chinese Medicine
进行中（未招募）
1 期
A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus iron sucrose (VENOFER®) for treatment of iron deficiency anaemia in patients with inflammatory bowel disease Estudio aleatorizado, multicéntrico, prospectivo y abierto para investigar la eficacia y la seguridad de una pauta de dosis de corrección normalizada de carboximaltosa férrica (FERINJECT®) administrada por vía intravenosa en comparación con sacarosa férrica (VENOFER®) para el tratamiento de la anemia ferropénica en pacientes con enfermedad inflamatoria intestinalEUCTR2008-002333-75-ESVifor (International) Inc.420
进行中（未招募）
不适用
A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus iron sucrose (VENOFER®) for treatment of iron deficiency anaemia in patients with inflammatory bowel diseaseIron deficiency anaemia in patients with inflammatory bowel diseaseMedDRA version: 9.1Level: LLTClassification code 10055736Term: Iron deficiency anaemia secondary to blood loss (chronic)EUCTR2008-002333-75-ATVifor (International) Inc.420
进行中（未招募）
不适用
A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus iron sucrose (VENOFER®) for treatment of iron deficiency anaemia in patients with inflammatory bowel diseaseEUCTR2008-002333-75-EEVifor (International) Inc.420
进行中（未招募）
不适用
A multi-centre, randomised, prospective, open-label study to investigate the efficacy and safety of a standardised correction dosage regimen of intravenous ferric carboxymaltose (FERINJECT®) versus iron sucrose (VENOFER®) for treatment of iron deficiency anaemia in patients with inflammatory bowel diseaseIron deficiency anaemia in patients with inflammatory bowel diseaseMedDRA version: 9.1Level: LLTClassification code 10055736Term: Iron deficiency anaemia secondary to blood loss (chronic)EUCTR2008-002333-75-DEVifor (International) Inc.420